Drugplain

ADMELOG 100 U/mL

insulin lispro · INJECTION, SOLUTION · Sanofi-Aventis U.S. LLC

No Recall History
Plain English

Admelog (insulin lispro) is a fast-acting insulin injection used to help control blood sugar levels in people with diabetes. It is given by injection into a vein or under the skin to replace the insulin your body normally makes.

Key Facts

Brand Name
ADMELOG
Generic Name
insulin lispro
NDC Code (Product)
0024-5926
Manufacturer
Sanofi-Aventis U.S. LLC
Strength
100 U/mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Marketing Status
Application #
BLA209196
Drug Class
Insulin Analog [EPC]
Marketing Start
10/19/2018

Recall History

No Recall History

Frequently Asked Questions

What is ADMELOG used for?

Admelog (insulin lispro) is a fast-acting insulin injection used to help control blood sugar levels in people with diabetes. It is given by injection into a vein or under the skin to replace the insulin your body normally makes.

Is ADMELOG a controlled substance?

ADMELOG is not classified as a controlled substance by the DEA.

What is the generic name for ADMELOG?

The generic name for ADMELOG is insulin lispro. There are 12 other brand versions of insulin lispro.

What is the NDC code for ADMELOG 100 U/mL?

The NDC (National Drug Code) for ADMELOG 100 U/mL is 0024-5926, listed by Sanofi-Aventis U.S. LLC.